Jade Biosciences (JBIO) Total Liabilities (2020 - 2026)

Jade Biosciences (JBIO) has 7 years of Total Liabilities data on file, last reported at $23.0 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 823.64% year-over-year to $23.0 million; the trailing twelve-month figure through Mar 2026 stood at $23.0 million (up 823.64% YoY), and the FY2025 full-year result was $17.3 million, down 85.57% from the prior year.
• Total Liabilities for Q1 2026 stood at $23.0 million, up from $17.3 million in the prior quarter.
• Across five years, Total Liabilities topped out at $119.6 million in Q4 2024 and bottomed at $2.5 million in Q1 2025.
• The 5-year median for Total Liabilities is $15.2 million (2023), against an average of $19.8 million.
• The widest annual swing landed in 2022, when Total Liabilities tumbled 94.49%; it then jumped 823.64% in 2026.
• A 5-year view of Total Liabilities shows it stood at $8.6 million in 2022, then jumped by 109.89% to $18.0 million in 2023, then jumped by 565.83% to $119.6 million in 2024, then tumbled by 85.57% to $17.3 million in 2025, then soared by 33.06% to $23.0 million in 2026.
• The last three Total Liabilities figures came in at $23.0 million (Q1 2026), $17.3 million (Q4 2025), and $23.1 million (Q3 2025), per Business Quant data.

Peer Comparison